Skip to main content
. 2022 Dec 11;37:e00777. doi: 10.1016/j.btre.2022.e00777

Table 4.

Candidates of the bioactive compounds and GtfB protein using molecular docking.

Compounds Binding energy (ΔG) Kcal/mol Inhibitory constant
(Ki) µM
Chlorhexidine (commercial drug) -16.04 1.75 × 10-6
C. citratus
Luteolin -9.39 0.13
Kaempferol -9.22 0.17
Isocaryophyllene -8.89 0.31
β-Caryophyllene oxide -8.33 0.79
β-Vatirenene -8.22 0.95
S. asper
3,3-Methylenebis(4-hydroxybenzaldehyde) -7.59 2.71
Vanillin -5.72 64.17
Palmitic acid -4.85 278.05
S. aromaticom
Quercetin -9.27 0.16
Kaempferol -9.22 0.17
Rhamnocitrin -8.73 0.40
Copaene -8.56 0.54
Biflorin -8.30 0.83
Gallic acid -7.59 2.71
2,3,4-Tri-methoxyacetophenone -6.90 8.73
Eugenol -6.50 17.34
Mixed Herbs
Luteolin -9.39 0.13
Quercetin -9.27 0.16
Kaempferol -9.22 0.17
Rhamnetin -8.97 0.27
β-Vatirenene -8.22 0.95
Gallic acid -7.59 2.71
Chlorogenic acid -6.77 10.94
Quercetin 3′-O-glucuronide -6.42 19.52
Palmitic acid -4.85 278.05
5-βH-16β-hydroxylkamaloside